EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Out-of-pocket expenditures and financial risks associated with treatment of vaccine-preventable diseases in Ethiopia: A cross-sectional costing analysis

Solomon Tessema Memirie iD, Mieraf Taddesse Tolla, Eva Rumpler iD, Ryoko Sato, Sarah Bolongaita iD, Yohannes Lakew Tefera, Latera Tesfaye, Meseret Zelalem Tadesse, Fentabil Getnet iD, Tewodaj Mengistu iD, Stéphane Verguet

PLOS Medicine · 10.03.2023 · 20 (3) · e1004198

DOI: 10.1371/journal.pmed.1004198 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS Medicine, online erschienen am 10.03.2023. Verfasst von Solomon Tessema Memirie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Addis Center for Ethics and Priority Setting, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Vaccine-Preventable Diseases, Whooping Cough. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GAVI Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vaccine-preventable diseases (VPDs) remain major causes of morbidity and mortality in low- and middle-income countries (LMICs). Universal access to vaccination, besides improved health outcomes, would substantially reduce VPD-related out-of-pocket (OOP) expenditures and associated financial risks. This paper aims to estimate the extent of OOP expenditures and the magnitude of the associated catastrophic health expenditures (CHEs) for selected VPDs in Ethiopia. Methods and findings We conducted a cross-sectional costing analysis, from the household (patient) perspective, of care-seeking for VPDs in children aged under 5 years for pneumonia, diarrhea, measles, and pertussis, and in children aged under 15 years for meningitis. Data on OOP direct medical and nonmedical expenditures (2021 USD) and household consumption expenditures were collected from 995 households (1 child per household) in 54 health facilities nationwide between May 1 and July 31, 2021. We used descriptive statistics to measure the main outcomes: magnitude of OOP expenditures, along with the associated CHE within households. Drivers of CHE were assessed using a logistic regression model. The mean OOP expenditures per disease episode for outpatient care for diarrhea, pneumonia, pertussis, and measles were $5·6 (95% confidence interval (CI): $4·3, 6·8), $7·8 ($5·3, 10·3), $9·0 ($6·4, 11·6), and $7·4 ($3·0, 11·9), respectively. The mean OOP expenditures were higher for inpatient care, ranging from $40·6 (95% CI: $12·9, 68·3) for severe measles to $101·7 ($88·5, 114·8) for meningitis. Direct medical expenditures, particularly drug and supply expenses, were the major cost drivers. Among those who sought inpatient care (345 households), about 13·3% suffered CHE, at a 10% threshold of annual consumption expenditures. The type of facility visited, receiving inpatient care, and wealth were significant predictors of CHE ( p -value < 0·001) while adjusting for area of residence (urban/rural), diagnosis, age of respondent, and household family size. Limitations include inadequate number of measles and pertussis cases.

Conclusions

The OOP expenditures induced by VPDs are substantial in Ethiopia and disproportionately impact those with low income and those requiring inpatient care. Expanding equitable access to vaccines cannot be overemphasized, for both health and economic reasons. Such realization requires the government’s commitment toward increasing and sustaining vaccine financing in Ethiopia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine-Preventable DiseasesWhooping CoughChildHumansHealth ExpendituresCross-Sectional StudiesEthiopiaCatastrophic Illness

Autor:innen und Institutionen

  • Addis Center for Ethics and Priority Setting, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Ministry of Heath of Ethiopia, Addis Ababa, Ethiopia.
  • National Data Management Center for Health, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Gavi, the Vaccine Alliance, Geneva, Switzerland.

ORCID-Profile: Solomon Tessema Memirie, Eva Rumpler, Sarah Bolongaita, Fentabil Getnet, Tewodaj Mengistu

Förderung

  • GAVI Alliance

Zitieren

APA

Memirie, S. T., Tolla, M. T., Rumpler, E., Sato, R., Bolongaita, S., Tefera, Y. L., Tesfaye, L., Tadesse, M. Z., Getnet, F., Mengistu, T., & Verguet, S. (2023). Out-of-pocket expenditures and financial risks associated with treatment of vaccine-preventable diseases in Ethiopia: A cross-sectional costing analysis. PLOS Medicine, 20(3), e1004198. https://doi.org/10.1371/journal.pmed.1004198

Vancouver

Memirie ST, Tolla MT, Rumpler E, Sato R, Bolongaita S, Tefera YL, et al. Out-of-pocket expenditures and financial risks associated with treatment of vaccine-preventable diseases in Ethiopia: A cross-sectional costing analysis. PLOS Medicine. 2023;20(3):e1004198. doi:10.1371/journal.pmed.1004198

BibTeX
@article{Memirie2023,
  author = {Memirie, Solomon Tessema and Tolla, Mieraf Taddesse and Rumpler, Eva and Sato, Ryoko and Bolongaita, Sarah and Tefera, Yohannes Lakew and Tesfaye, Latera and Tadesse, Meseret Zelalem and Getnet, Fentabil and Mengistu, Tewodaj and Verguet, Stéphane},
  title = {Out-of-pocket expenditures and financial risks associated with treatment of vaccine-preventable diseases in Ethiopia: A cross-sectional costing analysis},
  journal = {PLOS Medicine},
  year = {2023},
  volume = {20},
  number = {3},
  pages = {e1004198},
  doi = {10.1371/journal.pmed.1004198}
}
Kostenlos starten →